Psoriasis

Purpose Biologics are used to treat conditions such as moderate-to-severe psoriasis, a chronic condition that impairs quality of life as much or more than other major medical conditions. Biopharmaceuticals are medications which are are isolated from biological sources including microorganisms, animals or humans. These medications generally function to decrease …

FROM THE JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY Secukinumab is a safe and effective treatment option for patients with moderate to severe scalp psoriasis, according to Dr. Jerry Bagel of the Psoriasis Treatment Center of Central New Jersey, and his associates. After 12 weeks of treatment with 300 mg …

One World Cannabis Pharmaceutical Research (OWCP) and mediq Innovation Experts have partnered to introduce OWCP’s cannabinoid-based topical psoriasis cream in Germany. Germany-based mediq has extensive experience in assisting companies based in Israel enter European markets. Under the new agreement, mediq will support OWCP with both a scientific collaboration and in marketing …

University of Michigan researchers has shed more light on the genetic landscape behind the intricate mechanisms of psoriasis. The 16 new genetic markers they identified can explain 28% of the hereditary component of the skin disease, according to a study they published in Nature Communications “We know there are a …

University of Michigan researchers have shed more light on the genetic landscape behind the intricate mechanisms of psoriasis. The 16 new genetic markers they identified can explain 28% of the hereditary component of the skin disease, according to a study they published in Nature Communications “We know there are a …

One World CannabisÂ Pharmaceutical Research (OWCP) and mediq Innovation Experts have partnered to introduce OWCP’s cannabinoid-based topical psoriasis cream in Germany. Germany-based mediq has extensive experience in assisting companies based in Israel enter European markets. Under the new agreement, mediq will support OWCP with both a scientific collaboration and in marketing …

Pediatric psoriasis patients should be screened regularly to identify risk factors for comorbidities including depression, gastrointestinal problems, diabetes, and dyslipidemia, according to the debut guidelines issued by an expert panel. The National Psoriasis Foundation and the Pediatric Dermatology Research Alliance joined forces to assess the literature and develop recommendations for …

Janssen announced two new Phase 3 clinical trials for psoriasis for its investigational drug guselkumab. The company intends to explore the therapeutic use of guselkumab for psoriatic arthritis, but also aims to compare the effectiveness of guselkumab with Cosentyx (secukinumab) for moderate to severe plaque-type psoriasis. Guselkumab is a monoclonal …

Pfizer’s rheumatoid arthritis drug Xeljanz (tofacitinib) was effective against nail psoriasis in patients with plaque disease, according to data from two Phase 3 clinical trials. The data further expands the known effects of the treatment, which also has been shown effective in other types of psoriasis. The study, “Efficacy of …

Key clinical point: Adalimumab appears to be a safe and effective treatment for children with severe plaque psoriasis. Major finding: At week 16 of the initial treatment period, Psoriasis Area and Severity Index (PASI)175 was reached by significantly more of the patients in the 0.8 mg/kg adalimumab group (22 of …